Notorious OxyContin-maker Purdue Pharma – which has been widely criticized for deceptively marketing its highly addictive painkillers and overdose deaths; got to be an antidote to opioid overdoses.
The company has a fast-track system for the treatment of the disease. Purdue suggest that nalmefene HCl's effects are longer than the corresponding emergency opioid antagonist naloxone. As such, the company hopes nalmefene HCl will out-compete naloxone at reversing overdoses, namely fentanyl, which is currently driving the alarming numbers of opioid overdose deaths. The FDA's fast-track status will be the review and regulatory review of the drug.
“Opioid antagonists like naloxone have played an important role in the treatment of opioid overdose,” John Renger, Purdue's Head of Research & Development and Regulatory Affairs, received in a statement. "However, because of the increasing number of deaths, we are focusing on a lot more potent and longer-lasting rescue."
Deaths from the extremely potent fentanyl began spiking nationwide in 201
Amid the crisis, Purdue has been fiercely condemned for OxyContin, which it started aggressively marketing in the mid-1990s, earning the company billions of dollars in sales. 2007, the company and the executives are the doctors, patients, and regulators of the drug. Since then, Purdue has been pummeled by lawsuits blaming the company.
"What's right" involvement in initiating the epidemic, focusing on illicit drug use. Purdue's President and CEO, Craig Landau was quoted as describing the problem simply as “Fentanyl and Illicit Opioid Deaths.”
In a recent interview with the Washington Post Landau said they expected Purdue's efforts to treat opioid overdoses would be criticized, saying:
In line with that sentiment, Purdue announced that it doesn't intend to make money on the new drug. "Purdue's commitment to advance the outcome of the drug market."
Still, according to the internal discussions at Purdue of the Massachusetts, Purdue and members of the wealthy the epidemic.
An un-redacted section of the lawsuit of a secret plan called Project Tango. The lawsuit was a prime business opportunity. Purdue staff quoted in the law as quoted in the lawsuit. Large unmet need for susceptibility, dependence and addiction. "